We are live on ! Find out more
OL

Odyssean LLC Portfolio holdings

AUM $866M Turnover 38.09%
1-Year Est. Return 42.65%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+42.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$866M
AUM Growth
+$251M
Cap. Flow
+$260M
Cap. Flow %
30.08%
Top 10 Hldgs %
5.29%
Holding
575
New
90
Increased
217
Reduced
38
Closed
129
Avg Time Held
0.4 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0.1 years

Sector Composition

Rank Sector Weight
1 Technology 27.33%
2 Healthcare 16.37%
3 Financials 15.49%
4 Industrials 8.24%
5 Real Estate 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PR icon
51
Permian Resources
PR
$17.8B
$4.33M 0.5%
204,898
+52,524
+34% +$1.13M
2025 Q4
3 quarters
SAM icon
52
Boston Beer
SAM
$2.14B
$4.33M 0.5%
26,372
+10,028
+61% +$1.78M
2026 Q1
2 quarters
INVH icon
53
Invitation Homes
INVH
$15.3B
$4.33M 0.5%
164,278
+64,116
+64% +$1.87M
2025 Q4
3 quarters
HCI icon
54
HCI Group
HCI
$2.34B
$4.32M 0.5%
24,875
+6,347
+34% +$1.16M
2025 Q4
3 quarters
OWL icon
55
Blue Owl Capital
OWL
$6.11B
$4.32M 0.5%
475,585
+168,476
+55% +$1.77M
2026 Q2
1 quarter
TSLA icon
56
Tesla
TSLA
$1.37T
$4.32M 0.5%
12,178
+4,864
+67% +$1.74M
2025 Q4
3 quarters
DELL icon
57
Dell
DELL
$176B
$4.32M 0.5%
8,027
+512
+7% +$240K
2025 Q4
3 quarters
SSNC icon
58
SS&C Technologies
SSNC
$17.5B
$4.32M 0.5%
56,005
+12,080
+28% +$930K
2026 Q2
1 quarter
MPT icon
59
Medical Properties Trust
MPT
$1.04B
$4.31M 0.5%
1,245,672
+646,314
+108% +$2.72M
2025 Q4
3 quarters
BLK icon
60
Blackrock
BLK
$171B
$4.31M 0.5%
4,072
+1,191
+41% +$1.3M
2025 Q4
3 quarters
BBIO icon
61
BridgeBio Pharma
BBIO
$14.8B
$4.31M 0.5%
65,463
+24,448
+60% +$1.9M
2026 Q2
1 quarter
AHR icon
62
American Healthcare REIT
AHR
$13.4B
$4.31M 0.5%
84,018
+20,510
+32% +$1.12M
2025 Q4
3 quarters
JOBY icon
63
Joby Aviation
JOBY
$3.75B
$4.3M 0.5%
710,956
+578,680
+437% +$4.2M
2026 Q1
2 quarters
AMRX icon
64
Amneal Pharmaceuticals
AMRX
$7.4B
$4.29M 0.5%
213,239
+29,732
+16% +$536K
2025 Q4
3 quarters
DNLI icon
65
Denali Therapeutics
DNLI
$2.97B
$4.29M 0.5%
207,640
+82,578
+66% +$1.93M
2026 Q2
1 quarter
ED icon
66
Consolidated Edison
ED
$44.5B
$4.28M 0.49%
41,914
+23,147
+123% +$2.51M
2026 Q1
2 quarters
MSGE icon
67
Madison Square Garden
MSGE
$3.7B
$4.28M 0.49%
53,388
+12,936
+32% +$1.01M
2025 Q4
3 quarters
WTTR icon
68
Select Water Solutions
WTTR
$2.06B
$4.28M 0.49%
+216,113
New +$4.3M
2026 Q3
0 quarters
NXT icon
69
Nextpower
NXT
$10.4B
$4.27M 0.49%
54,840
+42,344
+339% +$3.97M
2025 Q4
3 quarters
ARES icon
70
Ares Management
ARES
$27.9B
$4.27M 0.49%
36,784
+14,747
+67% +$1.93M
2026 Q2
1 quarter
NIC icon
71
Nicolet Bankshares
NIC
$3.45B
$4.26M 0.49%
26,151
+6,139
+31% +$1.04M
2025 Q4
3 quarters
BX icon
72
Blackstone
BX
$88B
$4.26M 0.49%
38,023
+13,812
+57% +$1.81M
2026 Q2
1 quarter
SANM icon
73
Sanmina
SANM
$7.45B
$4.26M 0.49%
19,826
+11,705
+144% +$2.38M
2025 Q4
3 quarters
PCVX icon
74
Vaxcyte
PCVX
$8.85B
$4.26M 0.49%
74,855
+12,217
+20% +$712K
2025 Q4
3 quarters
HOMB icon
75
Home BancShares
HOMB
$5.69B
$4.26M 0.49%
151,065
+45,833
+44% +$1.38M
2025 Q4
3 quarters

Similar funds

Odyssean LLC's Q3 2026 Portfolio in Review

As of Q3 2026, Odyssean LLC held 575 positions worth $866M, up 41% from $615M the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Odyssean LLC deployed $260M of net new capital in Q3 2026, opening 90 new positions and adding to 217 existing holdings. Its largest new stake was BILL Holdings: 101,841 shares worth $4.33M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Mirum Pharmaceuticals, an estimated $1.83M trimmed.

  • Odyssean LLC's largest Q3 2026 buy was BILL Holdings: 101,841 shares worth $4.33M.
  • Odyssean LLC added most to Broadstone Net Lease in Q3 2026, an estimated $4.24M increase.
  • Odyssean LLC's biggest Q3 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $1.83M.
  • Odyssean LLC fully exited Ultragenyx Pharmaceutical in Q3 2026, selling an estimated $4.08M.
  • Odyssean LLC's ten largest holdings make up 5.3% of its $866M portfolio in Q3 2026.
  • Odyssean LLC opened 90 new positions and closed 129 in Q3 2026.
  • Odyssean LLC's portfolio value rose 41% quarter-over-quarter to $866M.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.